Evidence map›Paper›PMID 33519799›Full record

ArticleFrontiers in immunology2020

Role of TLR4 in Persistent

Nisha Nair, Mariana S Guedes, Adeline M Hajjar, Catherine Werts, Maria Gomes-Solecki

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. TLR4 competence and mouse models of sublethal leptospirosis.PLoS neglected tropical diseases · 2025
    Article
  5. Article
  6. Host and Species-Specificities of Pattern Recognition Receptors Upon Infection WithFrontiers in cellular and infection microbiology · 2022
    Review
  7. Article
  8. Hematogenous dissemination of pathogenic and non-pathogenicFrontiers in cellular and infection microbiology · 2022
    Article
  9. Understanding the Renal Fibrotic Process in Leptospirosis.International journal of molecular sciences · 2021
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Nisha NairDepartment of Microbiology, Immunology and Biochemistry, The University of Tennessee Health Science Center, Memphis, TN, United States.
Mariana S GuedesDepartment of Microbiology, Immunology and Biochemistry, The University of Tennessee Health Science Center, Memphis, TN, United States.
Adeline M HajjarDepartment of Comparative Medicine, University of Washington, Seattle, WA, United States.
Catherine WertsInstitut Pasteur, Biology and Genetics of the Bacterial Cell Wall Unit, Paris, France.
Maria Gomes-SoleckiDepartment of Microbiology, Immunology and Biochemistry, The University of Tennessee Health Science Center, Memphis, TN, United States.
University of Tennessee Health Science Center · USInstitut Pasteur · FRUniversity of Washington · US

Funding

Lab on a chip point of care assay for the rapid serodiagnosis of Lyme diseaseR44AI096551 · NIAID · IMMUNO TECHNOLOGIES, INC. · PI GOMES-SOLECKI, MARIA · 2014 to 2016
$3.0M
Point of care assay for serodiagnosis of LeptospirosisR43AI136551 · NIAID · IMMUNO TECHNOLOGIES, INC. · PI GOMES-SOLECKI, MARIA · 2018 to 2019
$600k
Role of TLR4 in persistent Leptospira infectionR21AI142129 · NIAID · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI GOMES-SOLECKI, MARIA · 2019 to 2020
$418k
NIAID NIH HHS R21 AI142129NIAID NIH HHS R43 AI136551NIAID NIH HHS R44 AI096551
6 · The paper itself

Abstract

Toll-Like Receptor (TLR) 4, the LPS receptor, plays a central role in the control of leptospirosis and absence of TLR4 results in lethal infection in mice. Because human TLR4 does not sense the atypical leptospiral-LPS, we hypothesized that TLR4/MD-2 humanized transgenic mice (huTLR4) may be more susceptible to leptospirosis than wild-type mice, and thus may constitute a model of acute human leptospirosis. We infected huTLR4 mice, which express human TLR4 but not murine TLR4, with a high dose of

Indexed as

Acute DiseaseAnimalsDisease SusceptibilityHumansKidneyLeptospira interrogansLeptospirosisLymphocyte Antigen 96MiceMice, Inbred C57BLMice, KnockoutToll-Like Receptor 4Lymphocyte Antigen 96Toll-Like Receptor 4humanized TLR4/MD-2 mouse modelinnate immunitykidneyLeptospiraleptospirosisTLR4

Identifiers

PMID33519799
PMCPMC7843520
OpenAlexW3123798347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.